Viewing Study NCT06223568

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:57 PM
Ignite Modification Date: 2026-01-29 @ 4:18 PM
Study NCT ID: NCT06223568
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2024-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of the Head and Neck View
None Oropharynx View
None Human Papillomavirus Viruses View
None Drug Therapy View
None Cancer Vaccine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant Chemotherapy View
None Oropharynx Cancer View
None Human Papillomavirus View
None Therapeutic Vaccine View